How can we help?

Or log in to create a case and view open cases.

Articles in this section

How to use the EPCS mailer

As part of Activating E-Prescribing of Controlled Substances (EPCS) in iPrescribe, you need to enter a verification code from a letter with QR code ("mailer") into iPrescribe.

This action finalizes your ability to e-prescribe controlled substances in iPrescribe. 

Prerequisite: Completed ID.me identity proofing AND started ID.me EPCS Activation

Reminder: You received 2 separate items in the mail:

  • An token to e-prescribe controlled substances
    • If you receive your token in the mail before the letter, please keep it; you'll use it immediately after you complete EPCS activation using the letter with QR code. 
  • A letter with QR code ("mailer") at your DEA-listed business; it should arrive 5-10 business days after you generated it as part of EPCS activation and is needed to complete EPCS activation

 

1. Receive your letter at your DEA-listed business address.

Step4_Mailer.png

2. Log in to iPrescribe.

3. Go to the main menu. 

 

iPrescribe-action-menu-button.png

(click to enlarge)

4. Select Activate EPCS.  

iPrescribe_ActivateEPCS_Continue.png

(click to enlarge)

5. Scan the QR code. Or, enter the 7-digit code located right below the QR code on the letter ("mailer"). 

Step4_8.PNG

(click to enlarge)

  • If you choose to scan the QR code, allow iPrescribe to access your camera, then scan. 

iPrescribe_CameraAccess.png iPrescribe_ScanforEPCS_Lg.png iPrescribe_ScanforEPCSPairing_Lg.png

 (click to enlarge)

  • Otherwise, manually enter the 7-digit code into iPrescribe. 

iPrescribe_Enter7DigitMailerCode.png   iPrescribe_Pairing7DigitCode.png

 (click to enlarge)

6. You will see a success message, indicating you are now authorized to begin electronically prescribing controlled substances (EPCS) using your two-factor authentication (login password and one-time pin from an authenticator). 

iPrescribe_MailerSuccess.png   iPrescribe_ActivateEPCS_FinalScreen.png

 (click to enlarge)

Was this article helpful?
0 out of 0 found this helpful

Comments

0 comments

Article is closed for comments.